U.S. Supreme Court Declines to Hear Pfizer’s Appeal in Celebrex Class Action

A A
The Supreme Court has declined to hear Pfizer’s appeal of a class action shareholder lawsuit accusing the company of misrepresenting the results of a clinical study of its arthritis drug Celebrex.

To View This Article:

Login

Subscribe To Drug Industry Daily